Canopy Growth Establishes Germany Based Operations Through the Acquisition of Licensed Distributor, MedCann GmbH

Warning message

The subscription service is currently unavailable. Please try again later.

Canopy Growth Corporation ("Canopy Growth" or the "Company") (CGC.TO)  today announced that it has entered into an agreement to acquire MedCann GmbH Pharma and Nutraceuticals (MedCann), a German-based pharmaceutical distributor who has successfully placed Tweed-branded cannabis strains in German pharmacies.

MedCann has proven its ability to navigate the complex regulatory environment for cannabis importation and distribution in Germany . With a highly experienced leadership team, led by Dr. Pierre Debs , it has established itself as a leading cannabis importer and distributor within Germany where the cannabis industry still relies solely on imported products.

" Germany has begun a process of enabling medical access to cannabis and through a policy that recognized Canopy as the first legal supply source from North America ," said Bruce Linton , Chairman and CEO of Canopy Growth Corporation. "This acquisition establishes a distinct and purely medicinal corporate entity that helps us today but...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.